Compare $DCOY vs $ONCO | Chartloom

Compare

$DCOY vs $ONCO

Decoy Therapeutics Inc · Onconetix Inc

DCOY

Decoy Therapeutics Inc

ONCO

Onconetix Inc

Compare $DCOY vs $ONCO

Comparing Decoy Therapeutics Inc and Onconetix Inc

DCOYDecoy Therapeutics Inc

ONCOOnconetix Inc

DCOYDecoy Therapeutics Inc

Market cap

$779K

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-97.0%

FCF yield

-1073.9%

ONCOOnconetix Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.3%

YTD performance

-99.2%

52W performance

-99.7%

FCF yield

-420.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DCOY

ONCO

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

ONCO

Onconetix Inc

Market Cap

DCOY$779K

ONCO$2M

Enterprise Value

DCOY$-8M

ONCO$-3M

Price

DCOY$1.47

ONCO$0.62

P/E Ratio

DCOYN/A

ONCON/A

P/S Ratio

DCOY3.42x

ONCO3.79x

EV/Sales

DCOY-33.00x

ONCO-5.18x

EV/EBITDA

DCOY0.00x

ONCO0.00x

P/B Ratio

DCOY0.75x

ONCO0.24x

P/FCF Ratio

DCOYN/A

ONCON/A

EV/FCF

DCOY0.90x

ONCO0.32x

PEG Ratio

DCOYN/A

ONCON/A

Forward P/E (NTM)

DCOYN/A

ONCON/A

Forward P/S (NTM)

DCOYN/A

ONCON/A

Revenue (TTM)

DCOY$228K

ONCO$646K

Revenue Growth (YoY)

DCOYN/A

ONCO-51.3%

Forward Rev Growth

DCOY0.0%

ONCO0.0%

Gross Margin (TTM)

DCOY48.6%

ONCO80.4%

Operating Margin (TTM)

DCOY0.0%

ONCO0.0%

EBITDA Margin (TTM)

DCOY-2668.9%

ONCO-1188.1%

Net Margin (TTM)

DCOY-6348.7%

ONCO-1578.8%

FCF Margin (TTM)

DCOY-3676.1%

ONCO-1596.2%

Net Income (TTM)

DCOY$-14M

ONCO$-10M

FCF (TTM)

DCOY$-8M

ONCO$-10M

EPS (TTM)

DCOY-$27.16

ONCO-$4.55

ROE (TTM)

DCOY-31523.0%

ONCO-9194.0%

ROA (TTM)

DCOY-16715.0%

ONCO-5376.0%

ROIC (TTM)

DCOY-31523.0%

ONCO-9080.0%

Cash

DCOY$8M

ONCO$6M

Debt

DCOY$0

ONCO$150K

Net Cash/Debt

DCOY$8M

ONCO$6M

Current Ratio (TTM)

DCOY1.83x

ONCO2.21x

Quick Ratio (TTM)

DCOY1.77x

ONCO2.04x

Debt/Equity (TTM)

DCOY0.00x

ONCO0.01x

Debt/Assets (TTM)

DCOY0.0%

ONCO0.0%

Interest Coverage (TTM)

DCOYN/A

ONCON/A

Net Debt/EBITDA (TTM)

DCOY0.00x

ONCO0.00x

Beta

DCOY0.68

ONCO2.60

52W Performance

DCOY-97.0%

ONCO-99.7%

YTD Performance

DCOY-81.2%

ONCO-99.2%

% from 52W High

DCOY-97.4%

ONCO-99.7%

% from 52W Low

DCOY0.7%

ONCO6.9%

Asset Turnover (TTM)

DCOY0.03x

ONCO0.03x

FCF Yield (TTM)

DCOY-1073.9%

ONCO-420.9%

Earnings Yield (TTM)

DCOY-1854.7%

ONCO-416.3%

Dividend Yield (TTM)

DCOYN/A

ONCON/A

Rule of 40

DCOY-3,676.1

ONCO-1,647.5

EV/GP/RG

DCOYN/A

ONCON/A

Ticker research

View DCOY research View ONCO research

Metric	DCOY Decoy Therapeutics Inc	ONCO Onconetix Inc
Market & Valuation
Market Cap	$779K	$2M
Enterprise Value	$-8M	$-3M
Price	$1.47	$0.62
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	3.79x
EV/Sales	-33.00x	-5.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	0.24x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$646K
Revenue Growth (YoY)	N/A	-51.3%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	48.6%	80.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2668.9%	-1188.1%
Net Margin (TTM)	-6348.7%	-1578.8%
FCF Margin (TTM)	-3676.1%	-1596.2%
Net Income (TTM)	$-14M	$-10M
FCF (TTM)	$-8M	$-10M
EPS (TTM)	-$27.16	-$4.55
ROE (TTM)	-31523.0%	-9194.0%
ROA (TTM)	-16715.0%	-5376.0%
ROIC (TTM)	-31523.0%	-9080.0%
Financial Health
Cash	$8M	$6M
Debt	$0	$150K
Net Cash/Debt	$8M	$6M
Current Ratio (TTM)	1.83x	2.21x
Quick Ratio (TTM)	1.77x	2.04x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	2.60
52W Performance	-97.0%	-99.7%
YTD Performance	-81.2%	-99.2%
% from 52W High	-97.4%	-99.7%
% from 52W Low	0.7%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.03x
FCF Yield (TTM)	-1073.9%	-420.9%
Earnings Yield (TTM)	-1854.7%	-416.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,676.1	-1,647.5
EV/GP/RG	N/A	N/A
Ticker research	View DCOY research	View ONCO research

Valuation

P/S Ratio

DCOY

3.42x

ONCO

3.79x

EV/FCF

ONCO

0.32x

DCOY

0.90x

Growth & revenue

Revenue Growth TTM

ONCO

-51.3%

Forward Revenue Growth

DCOY

0.0%

ONCO

0.0%

Profitability & performance

Gross Margin

ONCO

80.4%

DCOY

48.6%

ROE

ONCO

-9194.0%

DCOY

-31523.0%

FCF Yield %

ONCO

-420.9%

DCOY

-1073.9%

52-Week Performance

DCOY

-97.0%

ONCO

-99.7%

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

ONCO

Onconetix Inc

Market Cap

DCOY$779K

ONCO$2M

Enterprise Value

DCOY$-8M

ONCO$-3M

Price

DCOY$1.47

ONCO$0.62

P/E Ratio

DCOYN/A

ONCON/A

P/S Ratio

DCOY3.42x

ONCO3.79x

EV/Sales

DCOY-33.00x

ONCO-5.18x

EV/EBITDA

DCOY0.00x

ONCO0.00x

P/B Ratio

DCOY0.75x

ONCO0.24x

P/FCF Ratio

DCOYN/A

ONCON/A

EV/FCF

DCOY0.90x

ONCO0.32x

PEG Ratio

DCOYN/A

ONCON/A

Forward P/E (NTM)

DCOYN/A

ONCON/A

Forward P/S (NTM)

DCOYN/A

ONCON/A

Revenue (TTM)

DCOY$228K

ONCO$646K

Revenue Growth (YoY)

DCOYN/A

ONCO-51.3%

Forward Rev Growth

DCOY0.0%

ONCO0.0%

Gross Margin (TTM)

DCOY48.6%

ONCO80.4%

Operating Margin (TTM)

DCOY0.0%

ONCO0.0%

EBITDA Margin (TTM)

DCOY-2668.9%

ONCO-1188.1%

Net Margin (TTM)

DCOY-6348.7%

ONCO-1578.8%

FCF Margin (TTM)

DCOY-3676.1%

ONCO-1596.2%

Net Income (TTM)

DCOY$-14M

ONCO$-10M

FCF (TTM)

DCOY$-8M

ONCO$-10M

EPS (TTM)

DCOY-$27.16

ONCO-$4.55

ROE (TTM)

DCOY-31523.0%

ONCO-9194.0%

ROA (TTM)

DCOY-16715.0%

ONCO-5376.0%

ROIC (TTM)

DCOY-31523.0%

ONCO-9080.0%

Cash

DCOY$8M

ONCO$6M

Debt

DCOY$0

ONCO$150K

Net Cash/Debt

DCOY$8M

ONCO$6M

Current Ratio (TTM)

DCOY1.83x

ONCO2.21x

Quick Ratio (TTM)

DCOY1.77x

ONCO2.04x

Debt/Equity (TTM)

DCOY0.00x

ONCO0.01x

Debt/Assets (TTM)

DCOY0.0%

ONCO0.0%

Interest Coverage (TTM)

DCOYN/A

ONCON/A

Net Debt/EBITDA (TTM)

DCOY0.00x

ONCO0.00x

Beta

DCOY0.68

ONCO2.60

52W Performance

DCOY-97.0%

ONCO-99.7%

YTD Performance

DCOY-81.2%

ONCO-99.2%

% from 52W High

DCOY-97.4%

ONCO-99.7%

% from 52W Low

DCOY0.7%

ONCO6.9%

Asset Turnover (TTM)

DCOY0.03x

ONCO0.03x

FCF Yield (TTM)

DCOY-1073.9%

ONCO-420.9%

Earnings Yield (TTM)

DCOY-1854.7%

ONCO-416.3%

Dividend Yield (TTM)

DCOYN/A

ONCON/A

Rule of 40

DCOY-3,676.1

ONCO-1,647.5

EV/GP/RG

DCOYN/A

ONCON/A

Ticker research

View DCOY research View ONCO research

Metric	DCOY Decoy Therapeutics Inc	ONCO Onconetix Inc
Market & Valuation
Market Cap	$779K	$2M
Enterprise Value	$-8M	$-3M
Price	$1.47	$0.62
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	3.79x
EV/Sales	-33.00x	-5.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	0.24x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$646K
Revenue Growth (YoY)	N/A	-51.3%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	48.6%	80.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2668.9%	-1188.1%
Net Margin (TTM)	-6348.7%	-1578.8%
FCF Margin (TTM)	-3676.1%	-1596.2%
Net Income (TTM)	$-14M	$-10M
FCF (TTM)	$-8M	$-10M
EPS (TTM)	-$27.16	-$4.55
ROE (TTM)	-31523.0%	-9194.0%
ROA (TTM)	-16715.0%	-5376.0%
ROIC (TTM)	-31523.0%	-9080.0%
Financial Health
Cash	$8M	$6M
Debt	$0	$150K
Net Cash/Debt	$8M	$6M
Current Ratio (TTM)	1.83x	2.21x
Quick Ratio (TTM)	1.77x	2.04x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	2.60
52W Performance	-97.0%	-99.7%
YTD Performance	-81.2%	-99.2%
% from 52W High	-97.4%	-99.7%
% from 52W Low	0.7%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.03x
FCF Yield (TTM)	-1073.9%	-420.9%
Earnings Yield (TTM)	-1854.7%	-416.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,676.1	-1,647.5
EV/GP/RG	N/A	N/A
Ticker research	View DCOY research	View ONCO research